Cross-reactivity
Pulmonary Tuberculosis V
Pharmaceutical Poisoning: Treatment Strategies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pneumonia IV: Management
Anthelminthic Agents
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 23, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
François Lamontagne1, Christophe Clément, Thomas Fletcher
1From the Centre de Recherche Clinique, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada (F.L.); Réanimation Médicale, Polyclinique Bordeaux Nord Aquitaine, Bordeaux, France (C.C.); Liverpool School of Tropical Medicine, Liverpool, United Kingdom (T.F.); University of Washington, Seattle (S.T.J.); University of North Carolina at Chapel Hill, Chapel Hill (W.A.F.); and University of Toronto, Toronto (R.A.F.).
No abstract available in PubMed .